Back to the archive

The encyclopedia · Strategy & Leadership · Strategic decision · 2021–2024

Ayuga — Honasa/Mamaearth's Ayurvedic skincare brand that never found its market

Honasa Consumer shut Ayuga in August 2024 — launched Dec 2021, survived 2.5 years, ₹14.7Cr impairment loss, failed product-market fit

Honasa Consumer Ltd · Mamaearth · 2024-08-09

What happened

Ayuga was launched in December 2021 by Honasa Consumer Ltd, the parent company of Mamaearth, as an online-only ayurvedic beauty and skincare brand targeting Indian millennials. Honasa had built Mamaearth into a unicorn by selling toxin-free baby and beauty products, and Ayuga was meant to extend that success into the Ayurvedic wellness segment — one of the fastest-growing categories in Indian consumer goods. The brand was positioned as modern Ayurveda, with products like face washes, moisturisers, and serums made with traditional Indian ingredients in contemporary formats.

Despite being backed by Honasa's distribution, marketing muscle, and brand credibility, Ayuga never gained traction. The brand was revamped in late 2023 based on consumer feedback, but the relaunch failed to improve its trajectory. In June 2024, Honasa began sunsetting the brand. On 9 August 2024, during its Q1 earnings presentation, the company announced it was discontinuing Ayuga, citing poor product-market fit. The closure resulted in a one-time impairment loss of ₹14.7 crore ($1.77 million). About 20 employees were affected, some relocated to other Honasa brands.

After Ayuga's discontinuation, Honasa's portfolio was reduced to six brands: Mamaearth, The Derma Co, Aqualogica, Dr Sheth's, BBlunt, and Staze. The company's core business remained strong — Q1 FY25 operating revenue rose 19% YoY to ₹554 crore and net profit rose 62% YoY to ₹40 crore — but the Ayuga experiment showed that even a well-funded, well-connected brand could fail in India's increasingly crowded Ayurvedic beauty market, where competitors included Nathabit, The Ayurveda Company, and Kapiva.

Why it happened

  • Ayuga entered a market already crowded with established Ayurvedic brands and D2C competitors — Honasa's brand credibility was not enough to differentiate it from incumbents in the category
  • The online-only distribution model limited reach in a category where Ayurvedic consumers often rely on offline touchpoints like local chemists and traditional stores
  • The brand revamp in late 2023 failed to change its trajectory — the problem was not packaging or positioning but a fundamental lack of consumer demand for yet another Ayurvedic skincare brand
  • Honasa's disciplined approach to portfolio management meant Ayuga got a short leash — when it failed to find product-market fit in 2.5 years, the parent cut its losses rather than prolonging it
What it cost₹14.7Cr impairment loss; 2.5 years of operation, ~20 jobscostly

The lesson

A unicorn parent cannot guarantee a new brand's success — Honasa could manufacture, distribute, and market Ayuga, but it could not manufacture consumer demand for a brand nobody asked for.

Aftermath

Honasa announced Ayuga's discontinuation on 9 August 2024 during its Q1 FY25 earnings presentation. The brand had been sunsetting since June 2024. The closure resulted in a ₹14.7 crore impairment loss. Approximately 20 employees were affected, with some relocated to other Honasa brands. Honasa's portfolio was reduced to six brands: Mamaearth, The Derma Co, Aqualogica, Dr Sheth's, BBlunt, and Staze. The company's main business continued to grow, with Q1 FY25 revenue up 19% YoY to ₹554 crore.

Sources

spotted an error? The club wants to know.

Comments · 0

    Sign in to join the comments.

    More like this

    Somewhere, someone solved the problem this company failed at. 2nd Opinion →